Abstract
Human chorionic gonadotrophin (hCG) is a glycoprotein hormone normally secreted by trophoblastic cells of the placenta during pregnancy, which signals the differentiation of the trophoblast from the remainder of the blastocyst.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Belleville, F., Lasbenne, A., Nabet, P. and Paysant, P. (1978) HCS-HCG regulation in cultured placenta. Acta Endocrinol. 88, 169 - 181.
Maruo, T., Matsuo, T., Ohtani, T., Hoshina, M. and Mochizuki, M. (1986) Differential modulation of chorionic gonadotropin (CG) subunit messenger ribonucleic acid levels and CG secretion by progesterone in normal placenta and choriocarcinoma cultured in vitro. Endocrinology 119, 855 – 864.
Wilson, E.A., Jawad, M.J. and Dickson, L.R. (1980) Suppression of human chorionic gonadotropin by progestational steroids. Am. J. Obstet. Gynecol. 138, 708 – 713.
Wilson, E.A., Jawad, M.J. and Powel, D.E. (1984) Effect of estradiol and progesterone on human chorionic gonadotropin secretion in vitro. Am. J. Obstet. Gynecol. 149, 143 – 148.
Ho Yuen, B., Moon, Y.S. and Shin, D.H. (1986) Inhibition of human chorionic gonadotropin by prolactin from term human trophoblast. Am. J. Obstet. Gynecol. 154, 336 – 340.
Gibbons, J.M., Mitnick, M. and Chieffo, V. (1975) In vitrobiosynthesis of TSH- and LH-releasing factors by the human placenta. Am. J. Obstet. Gynecol. 121, 127 – 131.
Siler-Khodr, T.M. and Khodr, G. (1978) Content of luteinizing hormone - releasing factor in the human placenta. Am. J. Obstet. Gynecol. 130, 216 – 219.
Liotta, A.L. and Krieger, D.T. (1980) In vitrobiosynthesis and comparative posttranslational processing of immunoreactive precursor of corticotropin/beta-endorphin by human placental and pituitary cells. Endocrinology 106, 1504 – 1511.
Liotta, A.L., Houghten, R. and Krieger, D.T. (1982) Identification of a beta-endorphin-like peptide in cultured human placental cells. Nature, 295, 593 – 595.
Ahmed, M.S., Randall, L.W., Dass, B.S., Fridland, G., Desiderio, D.M. and Tolun, E. (1987) Identification of dynorphin 1–8 in human placenta by mass spectrometry. Life Sci. 40, 2067 – 2076.
Currie, A.J., Fraser, H.M. and Sharpe, R.M. (1981) Human placental receptors for luteinizing hormone-releasing hormone. Biochem. Biophys. Res. Commun. 99, 332 – 338.
Valette, A., Reme, J.M., Pontonnier, G. and Cros, J. (1980) Specific binding for opiate-like drugs in the placenta. Biochem. Pharmacol. 29, 2657 – 2661.
Ahmed, M.S., Byrne, W.L. and Klee, W.A. (1981) Solubilization of opiate receptors from human placenta. Placenta 3, 115 – 121.
Porthé, G., Valette, A. and Cros, J. (1981) Kappa-opiate binding sites in human placenta. Biochem. Biophys. Res. Commun. 101, 1 – 6.
Belisle, S., Petit, A., Gallo-Payet, N., Bellabarba, D., Lehoux, J.G. and Lemaire, S. (1988) Functional opioid receptors in human placentas. J. Clin. Endocrinol. Metab. 66, 283 – 289.
Khodr, G. and Siler-Khodr, T. (1978) The effect of luteinizing hormone releasing factor on human chorionic gonadotropin secretion. Fertil. Steril. 30, 301 – 314.
Siler-Khodr, T., Khodr, G., Valenzuela, G. and Rhode, J. (1986) Gonadotropin-releasing hormone effects on placental hormones during gestation: I. Alpha-human chorionic gonadotropin, human chorionic gonadotropin and human chorionic somatomammotropin. Biol. Reprod. 34, 245 – 254.
Valette, A., Tafani, M., Porthé, G., Pontonnier, B. and Cros, J. (1983) Placental kappa opiate-binding sites: interaction with dynorphin and its possible implication in hCG secretion. Life Sci. 33, 523 – 526.
Čemerikić, B., Genbačev, 0., Sulović, V. and Beaconsfield, R. (1988) Effect of morphine on hCG release by first trimester human trophoblast in vitro. Life Sci. 42, 1773 – 1779.
Petraglia, F., Sawchenko, P., Wlim, A.T., Rivier, J. and Vale, W. (1987) Localization, secretion and action of inhibin in human placenta. Science 237, 187 – 189.
Beaconsfield, R., Čemerikić, B., Genbačev, 0. and Šulović, V. (1987) The placenta as a model for toxicity screening of new molecules. In: “Trophoblast Research”. Editors: R.K. Miller and H.A. Thiede, Plenum Press, New York and London, pp 343 – 356.
Golander, A., Barrett, J.R., Tyrey, L., Fletcher, W.H. and Handwerger, S. (1978) Differential synthesis of human placental lactogen and human chorionic gonadotropin in vitro. Endocrinology 102, 597 – 605.
Ahmed, M.S. and Cavinato, A.G. (1987) Partial purification of the opioid receptor from human placenta. In: “Trophoblast Research”. Editors: R.K. Miller and H.A. Thiede, Plenum Press, New York and London, pp 279 – 287.
Petraglia, F., Fachineti, F., M’Futa, K., Ruspa, M., Bonavera, J.J., Gandolfi, F. and Genazzani, A.R. (1986) Endogenous opioid peptides in uterine fluid. Fertil. Steril. 46, 247 – 251.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Čemerikić, B., Genbačev, O. (1989). Tissue Explant Technique in the Study of Human Chorionic Gonadotrophin (hCG) Production In Vitro . In: Genbačev, O., Klopper, A., Beaconsfield, R. (eds) Placenta as a Model and a Source. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0823-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0823-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8100-9
Online ISBN: 978-1-4613-0823-2
eBook Packages: Springer Book Archive